Akslen is a certified specialist in surgical pathology and is directing the Tumor Biology Research Group (since the establishment in 1995) at Department of Clinical Medicine (University of Bergen). Since 2013, Akslen is the director of Centre for Cancer Biomarkers CCBIO. Akslen´s team, and now CCBIO, are engaged in translational cancer research with a strong focus on  exploration and validation of novel biomarkers for more biologically based classification and grading of malignant tumors, as a better guide for targeted treatment. The group has included projects on various cancers, such as breast cancer, malignant melanoma, prostate cancer, and gynecologic cancers. Studies of human tumor samples are combined with experimental cell and animal models to improve translation. The overall aim is to provide novel biomarkers which can assist in prediction of aggressive tumor behavior and be helpful in tailored treatment.

Academic article

• Ingunn Marie Stefansson; Gøril Knutsvik; Jarle Birger Arnes et al. (2025). Loss of androgen receptor expression is associated with aggressive tumor features and reduced survival in breast cancer patients. (external link)
• Astrid Andrine Syrtveit; Lise Martine Ingebriktsen; Amalie Fagerli Tegnander et al. (2025). Tumor necrosis associates with aggressive breast cancer features, increased hypoxia signaling and reduced patient survival. (external link)
• Lars A. Akslen (1994). Etiologiske og patobiologiske aspekter ved malignt melanom. (external link)
• Monica Mannelqvist; Ingunn Marie Stefansson; Geir Bredholt et al. (2011). Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer. (external link)
• Praveen Sharma; Narinder S Sahni; Robert Tibshirani et al. (2005). Early detection of brest cancer based on gene-expression patterns in peripheral blood cells. (external link)
• Ingunn Marie Stefansson; Helga Salvesen; Lars A. Akslen (2004). Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. (external link)
• Liv Cecilie Vestrheim Thomsen; Alfred Honore; Bjørn Tore Gjertsen et al. (2023). A prospective non-randomized phase I trial of dendritic cell–based cryoimmunotherapy combined with checkpoint inhibitors in mCRPC.. (external link)
• WD Foulkes; JS Brunet; Ingunn Marie Stefansson et al. (2004). The prognostic implication of the basal-like (cyclin E-high/p27(low)/p53(+)/glomeruloid-microvascular-proliferation(+)) phenotype of BRCA1-related breast cancer. (external link)
• Ole Johan Halvorsen; Svein Andreas Haukaas; Jens Høstmark et al. (1997). Expression of p16 protein in prostatic adenocarcinomas, intraepithelial neoplasia and benign/hyperplastic glands. (external link)
• Cornelia Schuster; Lars A. Akslen; Oddbjørn Straume (2016). Expression of Heat Shock Protein 27 in melanoma metastases is associated with overall response to bevacizumab monotherapy: Analyses of predictive markers in a clinical phase II study. (external link)
• Lars A. Akslen; Barbara Karwinski; H. Maartmann-Moe et al. (1991). Periodicity in metastatic tumour growth demonstrated in human liver at autopsy. (external link)
• Line Merethe Myklebust; Lars A. Akslen; Jan Erik Varhaug et al. (2011). Receptor for Activated Protein C Kinase 1 (RACK1) Is Overexpressed in Papillary Thyroid Carcinoma. (external link)
• Ingeborg Engelsen; Ingunn Marie Stefansson; Lars A. Akslen et al. (2006). Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas. (external link)
• Oddbjørn Straume; Lars A. Akslen (2005). Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma. (external link)
• Marit Valla; Lars Johan Vatten; Monica J Engstrøm et al. (2016). Molecular subtypes of breast cancer: Long-term incidence trends and prognostic differences. (external link)
• Lise Martine Ingebriktsen; Kenneth Finne; Lars Andreas Akslen et al. (2022). A novel age-related gene expression signature associates with proliferation and disease progression in breast cancer. (external link)
• Henrica Maria Johanna Werner; Anna Berg; Elisabeth Wik et al. (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. (external link)
• Even Birkeland; Elisabeth Wik; Siv Mjøs et al. (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. (external link)
• Katrin Kleinmanns; Katharina Bischof; Shamundeeswari Anandan et al. (2020). CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma. (external link)
• Øystein Fluge; Dagny R. Faksvåg Haugen; Lars A. Akslen et al. (2001). Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas. (external link)
• Stephanie Geisler; Per Eystein Lønning; T Aas et al. (1999). Influence of TP53 gene alterations and Her-2 expression on the respons to treatment with doxorubicin in locally advanced breast cancer. (Abs. no. 227). (external link)
• Jennifer H. Barrett; John C. Taylor; C Bright et al. (2015). Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. (external link)
• Oddbjørn Straume; Lars A. Akslen (1999). Loss of nuclear expression of p16 protein correlates with increased tumor cell proliferation and poor patient outcome in patients with vertical growth phase melanoma. (Abstract no. P-487). (external link)
• S Das; N MacDonald; A Ryan et al. (1999). The PTEN gene is methylated in endometrial carcinoma and associated with advanced disease and microsattelite instability. (Abs. no. 207). (external link)
• Trond H Paulsen; Turid Aas; Anne-Lise Børresen et al. (1997). Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. (external link)
• Lufei Sui; Suming Wang; Roberto Rodriguez et al. (2020). Notch1 regulates breast cancer stem cell function via a non-canonical cleavage-independent pathway. (external link)
• Dace Pjanova; Anders Molven; Lars A. Akslen et al. (2009). Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia. (external link)
• Helga Salvesen; Pål Rasmus Njølstad; Lars A. Akslen et al. (1991). Thyroid carcinoma. Results from a uniform surgical strategy 1971-1985. (external link)
• Helga Salvesen; Rajiv Kumar; Ingunn Marie Stefansson et al. (2005). Low frequency of BRAF and CDKN2A mutations in endometrial cancer. (external link)
• Solveig Hofvind; åsne Sørlien Holen; Hildegunn Siv Aase et al. (2019). Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. (external link)
• Erling Dahl Borkamo; Øystein Fluge; Olav Mella et al. (2008). Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. (external link)
• Astrid Børretzen; Lars Anders Rokne Reisæter; Anders Ringheim et al. (2023). Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer. (external link)
• Trond H Paulsen; Turid Aas; A-L Børresen et al. (1997). Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. (external link)
• George N. Naumov; Monique B. Nilsson; Tina Cascone et al. (2009). Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. (external link)
• Ingunn Stefansson; Maria B Ræder; Elisabeth Wik et al. (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. (external link)
• Dagny R. Faksvåg Haugen; Lars A. Akslen; Jan Erik Varhaug et al. (1992). Expression of c-erbB-2 protein in papillary thyroid carcinomas. (external link)
• Solveig Hofvind; Åsne Sørlien Holen; Turid Aas et al. (2015). Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. (external link)
• Mark M. Iles; D. Timothy Bishop; John C. Taylor et al. (2014). The effect on melanoma risk of genes previously associated with telomere length. (external link)
• BO Mæhle; Bjørn Ove Mæhle; Karin Collett et al. (2009). Estrogen receptor β– an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?. (external link)
• Lars A. Akslen; S. Nilssen; Gunnar Kvåle (1992). Reproductive factors and risk of thyroid cancer. A prospective study of 63090 women from Norway. (external link)
• Rita Grude Ladstein; Ingeborg M. Bachmann; Oddbjørn Straume et al. (2012). Tumor necrosis is a prognostic factor in thick cutaneous melanoma. (external link)
• Dagny R. Faksvåg Haugen; Lars A. Akslen; Jan Erik Varhaug et al. (1993). Demonstration of a TGF-_a-EGF receptor autocrine loop and c-myc protein overexpression in papillary thyroid carcinomas. (external link)
• WD Foulkes; Ingunn Marie Stefansson; PO Chappuis et al. (2003). Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. (external link)
• Steinar Østerbø Thoresen; Lars A. Akslen; E. Glattre et al. (1993). Thyroid cancer in children in Norway 1953-1987. (external link)
• Shokoufeh Shahrabi-Farahani; Lili Wang; Bernadette MM Zwaans et al. (2014). Neuropilin 1 expression correlates with differentiation status of epidermal cells and cutaneous squamous cell carcinomas. (external link)
• Cecilie Askeland; Elisabeth Wik; Kenneth Finne et al. (2020). Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Prognostic impact of morphometric nuclear grade in endometrial carcinoma. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1999). Prognostic significance of angiogenesis, Ki-67, p53 and p21 expression - a population-based endometrial carcinoma study. (external link)
• Elisabeth Wik; Maria B Ræder; Camilla Krakstad et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (external link)
• Kristi Krüger; Laxmi Silwal-Pandit; Elisabeth Wik et al. (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. (external link)
• Sura Mohammed Aziz; Elisabeth Wik; Gøril Knutsvik et al. (2017). Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. (external link)
• Agnete Engelsen; Katarzyna Wnuk-Lipinska; Sébastien Bougnaud et al. (2020). AXL is a driver of stemness in normal mammary gland and breast cancer. (external link)
• Ole Johan Halvorsen; Anne Margrete Øyan; Trond Hellem Bø et al. (2005). Gene expression profiles in prostate cancer: Association with patient subgroups and tumour differentiation. (external link)
• Karen Klepsland Mauland; Jone Trovik; Elisabeth Wik et al. (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. (external link)
• S. Rotevatn; Lars A. Akslen; Erik Bjelke (1988). Life-style and caridovascular mortality among Norwegian men (Abstract). (external link)
• Lars A. Akslen; RB Sothern (1998). Seasonal variations in the presentation and growth of thyroid cancer. (external link)
• Helga Salvesen; Lars A. Akslen; Grethe Albrektsen et al. (1998). Poorer survival of nulliparous women with endometrial carcinoma. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. (external link)
• Maria Lie Lotsberg; Gro Vatne Røsland; Austin James Rayford et al. (2022). Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models. (external link)
• Per Eystein Lønning; H Johnsen; Stephanie Geisler et al. (1999). TP53 as a predictor of response to chemotherapy in breast cancer. (external link)
• George N. Naumov; Elise Bender; David Zurakowski et al. (2006). A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype. (external link)
• Helga Birgitte Salvesen; Lars A. Akslen (2002). Molecular pathogenesis and prognostic factors in endometrial carcinoma. (external link)
• Lars Frich; Eystein Glattre; Lars A. Akslen (2001). Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway. (external link)
• Camilla Tvedt Ekanger; Fan Zhou; Dana Bohan et al. (2022). Human organotypic airway and lung organoid cells of bronchiolar and alveolar differentiation are permissive to infection by influenza and SARS-CoV-2 respiratory virus. (external link)
• Lars A. Akslen; Andreas O Myking; Helga Salvesen et al. (1993). Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. (external link)
• Ingunn Marie Stefansson; Helga Salvesen; Lars A. Akslen (2006). Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients. (external link)
• Leiv M Hove; Lars Andreas Akslen; Flora Hartveit (1987). Malignant melanoma of the skin. Changing clinical stage at presentation 1955-79. (external link)
• Lars A. Akslen; Andreas O Myking; Helga Salvesen et al. (1993). Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. (external link)
• Tina Fonnes; Jone Trovik; Per-Henrik D. Edqvist et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (external link)
• Lars A. Akslen; Knut-Jan Andersen; Rolf Bjerkvig (1988). Characteristics of Human and Rat Glioma Cells Grown in a Defined Medium. (external link)
• Jane M. Heuch; Ivar Heuch; Lars A. Akslen et al. (1998). Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. (external link)
• J Høstmark; T Aas; Lars A. Akslen et al. (1995). Lack of diagnostic value of DNA content and p53 immunostaining in normal, hyperplastic and neoplastic parathyroid tissue. (external link)
• Trude Eid Robsahm; Per Helsing; Yngvar Nilssen et al. (2018). High mortality due to cutaneous melanoma in norway: A study of prognostic factors in a nationwide cancer registry. (external link)
• Camilla Tvedt Ekanger; Maria Ramnefjell; Maren Sofie Faldalen Guttormsen et al. (2025). An Organoid Model for Translational Cancer Research Recapitulates Histoarchitecture and Molecular Hallmarks of Non-Small-Cell Lung Cancer. (external link)
• Endre Gabrielsen; Tom Wilsgaard; Hanne Frydenberg et al. (2025). Higher pre-diagnostic serum syndecan-4 levels are associated with increased breast cancer risk: a case-cohort study. (external link)
• Elisabeth Wik; Jone Trovik; Ole-Erik Iversen et al. (2009). Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. (external link)
• Lars A. Akslen; Jan Erik Varhaug; T Aas et al. (1994). Increase of endo- and exo-peptidases in thyroid tumours. (external link)
• Helga Salvesen; Lars A. Akslen (1997). Recurrence of endometrial carcinoma and the value of routine follow up. (external link)
• Camilla Krakstad; Jone Trovik; Elisabeth Wik et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (external link)
• Christine Gjerdrum; Crina Elena Tiron; Torill Høiby et al. (2010). Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. (external link)
• Stian Tornaas; Dimitrios Kleftogiannis; Siren Fromreide et al. (2024). Development of a high dimensional imaging mass cytometry panel to investigate spatial organization of tissue microenvironment in formalin-fixed archival clinical tissues. (external link)
• Else Marie Huuse; Siver Andreas Moestue; Evita Maria Lindholm et al. (2012). In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. (external link)
• Lars A. Akslen; T. Haldorsen; Steinar Østerbø Thoresen et al. (1991). Survival and cause of death in thyroid cancer: A population-based study of 2479 cases from Norway. (external link)
• Nataliia Moshina; Sofie Sebuødegård; Christoph I. Lee et al. (2018). Automated volumetric analysis of mammographic density in a screening setting: Worse outcomes for women with dense breasts. (external link)
• Gøril Knutsvik; Ingunn Stefansson; Sura Mohammed Aziz et al. (2014). Evaluation of Ki67 expression across distinct categories of breast cancer specimens: A Population-based study of matched surgical specimens, core needle biopsies and tissue microarrays. (external link)
• Trygve Lofterød; Elin Synnøve Mortensen; Hawa Nalwoga et al. (2018). Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. (external link)
• D.R. Faksvåg Haugen; J.E. Varhaug; Lars A. Akslen et al. (1998). Diagnostisk molekylærbiologi ved solide svulster: Thyreoideacancer. (external link)
• Leif M Hove; Lars A. Akslen (1999). Clinicopathological characteristics of melanomas of the hand. (external link)
• Øystein Fluge; Ove Bruland; Lars A. Akslen et al. (2006). Gene expression in poorly differentiated papillary thyroid carcinomas. (external link)
• Lufei Sui; Suming Wang; Debolina Ganguly et al. (2022). PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. (external link)
• Helga Salvesen; Lars A. Akslen (1999). Significance of tumor associated macrophages, VEGF and TSP-1 for angiogenesis and prognosis of endometrial carcinoma. (external link)
• Helga Salvesen; Lars A. Akslen (1999). Strong prognostic influence of reduced p16 protein expression in endometrial carcinomas. A large population based study. (Abstract no. 0-079). (external link)
• GO Ness; Dagny F. Faksvåg Haugen; Jan Erik Varhaug et al. (1996). Cytoplasmatic localization of EGF receptor in papillary thyroid carcinomas: Association with the 150-kDa receptor forms. (external link)
• Gøril Knutsvik; Karin Collett; Jarle Arnes et al. (2016). QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas. (external link)
• Anders Engeland; Steinar Tretli; Lars Andreas Akslen et al. (2006). Body size and thyroid cancer in two million Norwegian men and women. (external link)
• Ali Ozhand; Eunjung Lee; Anna H. Wu et al. (2013). Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. (external link)
• Biaoyang Lin; Angelita G. Utleg; Karsten Gravdal et al. (2008). WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence. (external link)
• Rezvan Ehsani; Inge Jonassen; Lars Andreas Akslen et al. (2023). LOCATOR: feature extraction and spatial analysis of the cancer tissue microenvironment using mass cytometry imaging technologies. (external link)
• Henrica Maria Johanna Werner; Jone Trovik; Mari Kyllesø Halle et al. (2014). Stathmin Protein Level, a Potential Peredictive Marker for Taxane Treatment Response in Endometrial Cancer. (external link)
• L Frich; Lars A. Akslen; E Glattre (1997). Increased risk of thyroid cancer among Norwegian females married to fishery workers. (external link)
• Nataliia Moshina; Giske Ursin; Solveig Roth Hoff et al. (2015). Mammographic density and histopathologic characteristics of screen-detected tumors in the Norwegian Breast Cancer Screening Program. (external link)
• Yngve Nygård; Svein Andreas Haukaas; Jo Erling Riise Waage et al. (2012). Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97 % of significant prostate cancers. (external link)
• Diego A Garcia-Dios; Diether Lambrechts; Lieve Coenegrachts et al. (2013). High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. (external link)
• Merete Ellingjord-Dale; Eunjung Lee; Elisabeth Couto et al. (2012). Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users. (external link)
• Torbjørn Østvik Pedersen; Anna Blois; Zhe Xing et al. (2013). Endothelial microvascular networks affect gene-expression profiles and osteogenic potential of tissue-engineered constructs. (external link)
• Lars Anders Rokne Reisæter; Ole Johan Halvorsen; Christian Beisland et al. (2020). Assessing extraprostatic extension by mpMRI of the prostate: Mehralivand’s EPE grade or EPE Likert score?. (external link)
• Rune Småland; Lars A. Akslen; Bjarne Tønder et al. (1991). Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. (external link)
• Siver Andreas Moestue; Else Marie Huuse; Evita Maria Lindholm et al. (2013). Low-molecular contrast agent DCE-MRI and DW-MRI in early assessment of bevacizumab treatment in breast cancer xenografts. (external link)
• Hege Oma Ohnstad; Egil Støre Blix; Lars Andreas Akslen et al. (2024). Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1). (external link)
• Helga B. Salvesen; Mine G Gulluoglu; Ingunn Marie Stefansson et al. (2003). Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. (external link)
• Stephanie Geisler; Anne-Lise Børresen-Dale; Hilde Johnsen et al. (2003). TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer. (external link)
• Elisabeth Wik; Even Birkeland; Jone Trovik et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (external link)
• Øystein Fluge; K Gravdal; E Carlsen et al. (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. (external link)
• Lars A. Akslen (1996). Thyroid carcinomas with tall-cell and columnar-cell features (letter). (external link)
• GO Ness; Rolf Bjerkvig; Lars A. Akslen et al. (1995). Primary organ culture of non-neoplastic and neoplastic thyroid tissue as multicellular spheroids. (external link)
• Raúl Catena; Nandita Bhattacharya; Tina El Rayes et al. (2013). Bone marrow-derived Gr1(+) cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1. (external link)
• Rita Grude Ladstein; Ingeborg M. Bachmann; Oddbjørn Straume et al. (2010). Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. (external link)
• Dagny R. Faksvåg Haugen; Jan Erik Varhaug; Lars A. Akslen et al. (1998). Diagnostisk molekylærbiologi ved solide svulster - thyreoidea. (external link)
• Ingunn Marie Stefansson; Helga Salvesen; Lars A. Akslen (2006). Vascular proliferation is important for clinical progress of endometrial cancer. (external link)
• Turid Aas; Stephanie Geisler; Trond H Paulsen et al. (1996). Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; Clinical experience and parameters predicting outcome. (external link)
• GO Ness; Rolf Bjerkvig; Lars A. Akslen et al. (1995). Primary organ culture of non-neoplastic and neoplastic thyroid tissue as multicellular spheroids. (external link)
• Ingrid Vandenput; Jone Trovik; Karin Leunen et al. (2011). Evolution in endometrial cancer evidence from an immunohistochemical study. (external link)
• Cornelia Schuster; Lars A. Akslen; Tomasz Stokowy et al. (2019). Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy. (external link)
• Monica J Engstrøm; Signe Opdahl; Anne Irene Hagen et al. (2013). Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients. (external link)
• Ingvild Løberg Tangen; Jennifer Taylor Venereis; Mari Kyllesø Halle et al. (2017). Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. (external link)
• Lars A. Akslen (1993). Prognostic importance of histologic grading in papillary thyroid carcinoma. (external link)
• Lars Andreas Akslen; Leiv M Hove (1987). Malignt melanom - amelanotisk type. (external link)
• Amalie Abrahamsen Svanøe; Rasmus Olai Collett Humlevik; Gøril Knutsvik et al. (2024). Age-related phenotypes in breast cancer: A population-based study. (external link)
• Ole J. Halvorsen; Sven Haukaas; Per Åge Høisæter et al. (2001). Maximum Ki-67 staining in prostate cancer provides independent prognostic information after radical prostatectomy. (external link)
• Trygve Lofterød; Hanne Frydenberg; Vidar Gordon Flote et al. (2020). Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study. (external link)
• Elisabeth Wik; Jone Trovik; Kanthida Kusonmano et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (external link)
• Tor Audun Klingen; Ying Chen; Ingunn Stefansson et al. (2016). Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival. (external link)
• Dariush Etemadmoghadam; Anna deFazio; Rameen Beroukhim et al. (2009). Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas. (external link)
• Tone Hoel Lende; Marie Austdal; Anne Elin Varhaugvik et al. (2019). Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients - a randomized trial. (external link)
• Jarle Arnes; Karin Collett; Lars A. Akslen (2008). Lesson of the Month - Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. (external link)
• Hans Petter Eikesdal; Oddbjørn Straume; Lars A. Akslen et al. (2004). Karnydanning og tumorkar som mål for kreftterapi. (external link)
• Ingrid Moen; Alison Charlotte Jevne; Jian Wang et al. (2012). Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. (external link)
• Ingunn Marie Stefansson; Lars A. Akslen; N MacDonald et al. (2002). Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. (external link)
• Kristi Krüger; Elisabeth Wik; Gøril Knutsvik et al. (2017). Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer. (external link)
• Lars A. Akslen; Knut-Jan Andersen; Rolf Bjerkvig (1988). Characteristics of Human and Rat Glioma Cells Grown in a Defined Medium. (external link)
• Jane M. Heuch; Ivar Heuch; Lars A. Akslen et al. (1998). Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. (external link)
• J Høstmark; T Aas; Lars A. Akslen et al. (1995). Lack of diagnostic value of DNA content and p53 immunostaining in normal, hyperplastic and neoplastic parathyroid tissue. (external link)
• Trude Eid Robsahm; Per Helsing; Yngvar Nilssen et al. (2018). High mortality due to cutaneous melanoma in norway: A study of prognostic factors in a nationwide cancer registry. (external link)
• Anna Kristine Myrmel Sæle; Amalie Abrahamsen Svanøe; Cecilie Askeland et al. (2025). Reduced GATA3 expression associates with immuno-metabolic alterations and aggressive features in breast cancer. (external link)
• Maren Høibø; Andre Pedersen; Vibeke Grotnes Dale et al. (2025). Immunohistochemistry guided segmentation of benign epithelial cells, in situ lesions, and invasive epithelial cells in breast cancer slides. (external link)
• Soroush Oskouei; André Pedersen; Marit Valla et al. (2025). Low-Cost Lung Cancer Classification in WSIs Using a Foundation Model and Evolving Prototypes. (external link)
• Nataliia Moshina; Ragnhild Sørum Falk; Edoardo Botteri et al. (2025). Long-term quality of life and quality adjusted life years after breast cancer: Impact of detection mode, tumor characteristics and treatment. (external link)
• Hannah Ni Bhriain; Jone Trovik; Elisabeth Wik et al. (2009). Plasma calprotectin concentrations in women with endometrial carcinoma. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Independent prognostic importance of microvessel density in endometrial carcinoma. (external link)
• Tor Audun Klingen; Ying Chen; Hans Aas et al. (2024). DDR2 expression in breast cancer is associated with blood vessel invasion, basal-like tumors, tumor associated macrophages, regulatory T cells, detection mode and prognosis. (external link)
• JN Kitinya; MP Mbonde; HJ Guthe et al. (1994). Ploidy and proliferative rates in carcinomas of the breast in Tanzania. (external link)
• Ove Bruland; Øystein Fluge; Lars A. Akslen et al. (2009). Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas. (external link)
• TO Nielsen; FD Hsu; K Jensen et al. (2004). Immunohistochemical and Clinical Characterization of the Basal-like Subtype of Invasive Breast Carcinoma. (external link)
• Ole J. Halvorsen; Sven Haukaas; Lars A. Akslen (2003). Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. (external link)
• Hanna Røgenes; Kenneth Finne; Ingeborg Winge et al. (2024). Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry. (external link)
• Elisabeth Wik; Sura Mohammed Aziz; Heidrun Vethe et al. (2022). Neurogenesis and angiogenesis are associated features of aggressive breast cancer. (external link)
• Karin Collett; Geir Egil Eide; Jarle Arnes et al. (2006). Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. (external link)
• Ole Vidhammer Bjørnstad; Manuel Carrasco Fernandez; Kenneth Finne et al. (2024). Global and single-cell proteomics view of the co-evolution between neural progenitors and breast cancer cells in a co-culture model. (external link)
• Else Marie Opsahl; Lars A. Akslen; Ellen Schlichting et al. (2019). The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway. (external link)
• Ingrid Moen; Anne Margrete Øyan; Karl-Henning Kalland et al. (2009). Hyperoxic treatment induces mesenchymal to epithelial transition in a rat adenocarcinoma model. (external link)
• Jun Fang; Jinping Jia; Matthew Makowski et al. (2017). Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. (external link)
• CM Perou; T Sørlie; MB Eisen et al. (2000). Molecular portraits of human breast tumours. (external link)
• Carina Strell; Dick Folkvaljon; Erik Holmberg et al. (2021). High PDGFRB expression predicts resistance to radiotherapy in DCIS within the SweDCIS randomized trial. (external link)
• Sameer Bhargava; Lars A. Akslen; Ida Rashida Khan Bukholm et al. (2019). Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme. (external link)
• Hanne Eknes Puntervoll; Xiaohong R. Yang; Hildegunn Høberg Vetti et al. (2013). Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. (external link)
• Tone Hoel Lende; Marie Austdal; Tone Frost Bathen et al. (2019). Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study. (external link)
• Kari Rostad; Olaf JC Hellwinkel; Svein Andreas Haukaas et al. (2009). TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. (external link)
• Svein Andreas Haukaas; Ole Johan Halvorsen; Lars Dæhlin et al. (2006). Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical 14 retropubic prostatectomy for localized prostate cancer?. (external link)
• Anders Molven; Magne B. Grimstvedt; Solrun Steine et al. (2005). A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. (external link)
• Jane M. Heuch; Ivar Heuch; Lars A. Akslen et al. (1998). Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. (external link)
• Lars A. Akslen; Jan Erik Varhaug; T Aas et al. (1994). Increase of endo-and exo-peptidases in thyroid tumors. (external link)
• Hanne Frydenberg; Inger Thune; Trygve Lofterød et al. (2016). Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival. (external link)
• Monica Mannelqvist; Ingunn Marie Stefansson; Helga Birgitte Salvesen et al. (2009). Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. (external link)
• Hawa Nalwoga; Jarle Arnes; Henry Wabinga et al. (2010). Expression of aldehyde dehydrogenase a (ALDH1) is associated with basal-like markers and features of aggressive tumors in African breast cancer. (external link)
• Soo-Young Kang; Ole Johan Halvorsen; Karsten Gravdal et al. (2009). Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1. (external link)
• Liv Cecilie Vestrheim Thomsen; Alfred Honore; Lars Anders Rokne Reisæter et al. (2023). A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer. (external link)
• PA Ellis; Per Eystein Lønning; Turid Aas et al. (1997). Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. (external link)
• Rūta Veinalde; Aija Ozola; Kristine Azarjana et al. (2013). Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation. (external link)
• Lars Asphaug; Lars Andreas Akslen; Egil Støre Blix et al. (2025). Cost-Effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives. (external link)
• Martin Pilskog; Christian Beisland; Lars A. Akslen et al. (2017). Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (external link)
• Lars A. Akslen; Jan Erik Varhaug; T Aas et al. (1994). Increase of endo- and exo-peptidases in thyroid tumors. (external link)
• Lars A. Akslen (1994). Kreft i skjoldbruskkjertelen - økning i yngre årskull. (external link)
• Helga Salvesen; Pål Rasmus Njølstad; Lars A. Akslen et al. (1992). Disease free and cause specific survival in patients with papillary thyroid carcinoma. A multifactorial analysis. (external link)
• Fiona M. Blows; Kristy E. Driver; Marjanka K. Schmidt et al. (2010). Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. (external link)
• Kaitlyn Tsuruda; Solveig Kristin Roth Hoff; Lars Andreas Akslen et al. (2023). Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Independent prognostic importance of microvessel density in endometrial carcinoma. (external link)
• Jarle Arnes; Ingunn Marie Stefansson; Oddbjørn Straume et al. (2012). Vascular proliferation is a prognostic factor in breast cancer. (external link)
• Lars A. Akslen; Andreas O Myking (1992). Differentiated thyroid carcinomas: the relevance of various pathological features for tumour classification and prediction of tumour progress. (external link)
• Helga Birgitte Salvesen; Scott L. Carter; Monica Mannelqvist et al. (2009). Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. (external link)
• Ernst Von Dobschuetz; Helena Leijon; Camilla Schalin-Jäntti et al. (2015). A registry-based study of thyroid paraganglioma: histologic and genetic characteristics. (external link)
• Akinyemi Ojesina; Lee Lichtenstein; Samuel S. Freeman et al. (2014). Landscape of genomic alterations in cervical carcinomas. (external link)
• Astrid Børretzen; Karsten Gravdal; Svein Andreas Haukaas et al. (2021). The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients. (external link)
• T Aas; A-L Børresen; Stephanie Geisler et al. (1996). Relationship between mutations in the TP53 gene and De Novo resistance and early relapse following treatment with doxorubicin in patients with breast cancer. (external link)
• Martin Biermann; Jostein Kråkenes; Katrin Brauckhoff et al. (2015). Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity. (external link)
• M.R. Mirza; Luka Tandaric; J.R. Henriksen et al. (2024). NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer. (external link)
• Cornelia Schuster; Lars Andreas Akslen; Oddbjørn Straume (2023). β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma. (external link)
• T Aas; A-L Børresen; D Geisler et al. (1996). Spesific TP53 gene mutations are associated with de novo resistance to doxorubicin in breast cancer patients. (external link)
• Lars A. Akslen; B.O. Mæhle; Jan Erik Varhaug (1996). Aggressive thyroid carcinoma with predominant cribriform growth pattern. (external link)
• Maria B Ræder; Even Birkeland; Jone Trovik et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (external link)
• Mark M. Iles; Matthew H. Law; Simon N. Stacey et al. (2013). A variant in FTO shows association with melanoma risk not due to BMI. (external link)
• Jonas Evensen Thy; Sameer Bhargava; Marthe Larsen et al. (2022). Early screening outcomes among non-immigrants and immigrants targeted by BreastScreen Norway, 2010–2019. (external link)
• L Frich; Lars A. Akslen; E Glattre (1998). Økt forekomst av kreft i skjoldkjertelen blant norske kvinner gift med fiskere. (external link)
• Xisong Ke; Yi Qu; Naomi Goldfinger et al. (2008). Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation. (external link)
• Turid Aas; Anne-Lise Børresen; Stephanie Geisler et al. (1996). Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. (external link)
• Kristi Krüger; Ingunn Marie Stefansson; Karin Collett et al. (2012). Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer. (external link)
• Marit Valla; Monica J Engstrøm; Borgny Ytterhus et al. (2017). FGD5 amplification in breast cancer patients is associated with tumor proliferation and a poorer prognosis. (external link)
• Thomas Arnesen; Nina Glomnes; Siri S. Strømsøy et al. (2013). Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway. (external link)
• Tor Audun Klingen; Ying Chen; Hans Aas et al. (2017). Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer. (external link)
• J Høstmark; T Aas; Lars A. Akslen et al. (1995). Lack of diagnostic value of DNA content and p53 immunostaining in normal, hyperplastic and neoplastic parathyroid tissue. (external link)
• Trude Eid Robsahm; Per Helsing; Yngvar Nilssen et al. (2018). High mortality due to cutaneous melanoma in norway: A study of prognostic factors in a nationwide cancer registry. (external link)
• Maren Høibø; Ute Spiske; Andre Pedersen et al. (2025). Predicting estrogen receptor status from HE-stained breast cancer slides using artificial intelligence. (external link)
• Helga Salvesen; Lars A. Akslen; Torbjørn Iversen et al. (1997). Recurrence of endometrial carcinoma and the value of routine follow up. (external link)
• Lars A. Akslen (1994). Thyroid cancer: some aspects of epidemiology and etiological factors, pathological features and tumour biology. (external link)
• Jennifer H. Barrett; MM Iles; M Harland et al. (2011). Genome-wide association study identifies three new melanoma susceptibility loci. (external link)
• Tor Audun Klingen; Herman Klaasen; Ying Chen et al. (2009). Secondary breast cancer: a 5-year population-based study with review of the literature. (external link)
• E Vuhahula; Oddbjørn Straume; Lars A. Akslen (2000). Frequent loss of p16 protein expression and high proliferative activity (Ki-67) in malignant melanoma from black Africans. (external link)
• Matthew H. Law; D. Timothy Bishop; Jeffrey E. Lee et al. (2015). Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. (external link)
• Therese Sørlie; Charles M. Perou; Cheng Fan et al. (2006). Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. (external link)
• Ingunn Marie Stefansson; Helga Salvesen; Lars A. Akslen (2004). Prognostic impact of histological grade and vascular invasion compared with tumor cell proliferation in endometrial carcinoma of endometrioid type. (external link)
• Ingeborg Bachmann; Oddbjørn Straume; Lars A. Akslen (2004). Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas. (external link)
• O Straume; Lars A. Akslen (1997). Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. (external link)
• Vladan Milosevic; Reidunn Jetne Edelmann; Ingeborg Winge et al. (2023). Vessel size as a marker of survival in estrogen receptor positive breast cancer. (external link)
• ND Macdonald; Helga Salvesen; A Ryan et al. (2004). Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series. (external link)
• Emilia Signe Hugdahl; May Britt Kalvenes; Monica Mannelqvist et al. (2017). Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and secondary cutaneous melanoma. (external link)
• Lars A. Akslen; Oddbjørn Straume; Stephanie Geisler et al. (2011). Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer. (external link)
• Per Eystein Lønning; H Johnsen; Stephanie Geisler et al. (1999). TP53 as a predictor of response to chemotherpy in breast cancer. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1999). Prognostic value of tumor angiogenesis, Ki67, p53 and p21 protein expression - a population based endometrial carcinoma study. (external link)
• Oddbjørn Straume; Helga Salvesen; Lars A. Akslen (1999). Angiogenesis is prognostically important in vertical growth phase melanomas. (external link)
• Lars A. Akslen; Sabrina Angelini; Oddbjørn Straume et al. (2005). BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1999). Prognostic significance of tumor angiogenesis, Ki-67, p53 and p21 expression - a population-based endometrial carcinoma study. (external link)
• PA Ellis; Per Eystein Lønning; Turid Aas et al. (1997). Absence of p21 Expression is associated with abnormal p53 in human breast carcinomas. (external link)
• Lars A. Akslen; Odd Mørkve (1992). Expression of p53 protein in cutaneous melanoma. (external link)
• Lars Anders Rokne Reisæter; Jürgen J. Futterer; Are Losnegård et al. (2017). Optimising preoperative risk stratification tools for prostate cancer using mpMRI. (external link)
• Karsten Gravdal; Ole Johan Halvorsen; Svein Andreas Haukaas et al. (2009). Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. (external link)
• Nataliia Moshina; Ragnhild Sørum Falk; Edoardo Botteri et al. (2021). Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway. (external link)
• Maria Teresa Landi; David Timothy Bishop; Stuart MacGregor et al. (2020). Genome-Wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. (external link)
• Maria Ramnefjell; Christina Aamelfot; Lars Helgeland et al. (2017). Vascular invasion is an adverse prognostic factor in resected non?small-cell lung cancer. (external link)
• L. Dæhlin; Lars A. Akslen; Svein Andreas Haukaas (1991). Squamous cell carcinoma of the urinary bladder. (external link)
• Ole Johan Halvorsen; Kari Rostad; Anne Margrete Øyan et al. (2007). Increased expression of sim2-s protein is a novel marker of aggressive prostate cancer. (external link)
• Stian Knappskog; Elisabet Ognedal Berge; Ranjan Chrisanthar et al. (2015). Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo. (external link)
• Hilde Ytre-Hauge Smeland; Cecilie Askeland; Elisabeth Wik et al. (2019). Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes.. (external link)
• Ying Chen; Tor Audun Klingen; Elisabeth Wik et al. (2014). Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study. (external link)
• Tor Audun Klingen; Ying Chen; Hans Aas et al. (2021). Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer. (external link)
• Jessica Furriol Palmer; Elisabeth Wik; Sura Mohammed Aziz et al. (2024). VEGFA gene variants are associated with breast cancer progression. (external link)
• Solveig Hofvind; åsne Sørlien Holen; Martha Roman et al. (2016). Mode of detection: an independent prognostic factor for women with breast cancer.. (external link)
• Konstantina Dimitrakopoulou; Elisabeth Wik; Lars A. Akslen et al. (2018). Deblender: A semi-/unsupervised multi-operational computational method for complete deconvolution of expression data from heterogeneous samples. (external link)
• Per Helsing; Dag Andre Nymoen; Helge Rootwelt et al. (2012). MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas. (external link)
• F Alexander-Sefre; Helga B. Salvesen; N Abeler et al. (2003). Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis. (external link)
• Peder Gjengstø; Ole J. Halvorsen; Lars A. Akslen et al. (2003). Benign growth of different prostate zones in aging men with slightly elevated PSA in whom prostate cancer has been excluded: a prospective study of 510 patients. (external link)
• Astrid Børretzen; Karsten Gravdal; Svein Andreas Haukaas et al. (2019). FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer. (external link)
• Carina Strell; Axel Stenmark Tullberg; Reidunn Jetne Edelmann et al. (2021). Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial. (external link)
• Turid Aas; Stephanie Geisler; Geir Egil Eide et al. (2003). Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy. (external link)
• SE Halford; EJ Sawyer; MB Lambros et al. (2003). MSI-low, a real phenomenon which varies in frequency among cancer types. (external link)
• O Straume; Lars A. Akslen (1996). Independent prognostic importance of vascular invasion in nodular melanomas. (external link)
• Yngve Nygård; Svein Andreas Haukaas; Ole Johan Halvorsen et al. (2014). A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting. (external link)
• Helga Salvesen; Lars A. Akslen; Grethe Albrektsen et al. (1998). Decreased survival for nulliparous women with endometrial carcinoma. Is the relationship due to biology or behaviour?. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Identification of high-risk patients by assessment of nuclear Ki67 expression in a prosepective study of endometrial carcinoma patients. (external link)
• Helga Salvesen; Lars A. Akslen (1999). Significance of tumor associated macrophages. VEGF and TSP-1 expression for tumor angiogenesis and prognosis in endometrial carcinomas. (external link)
• Hawa Nalwoga; Jarle Arnes; Henry Wabinga et al. (2007). Frequency of the basal-like phenotype in African breast cancer. (external link)
• Lars A. Akslen (1996). Incidence of thyroid cancer in New Caledonia, South Pacific, during 1985-1992 (letter). (external link)
• Michael Brauckhoff; Jan Erik Varhaug; Steffen Hauptmann et al. (2012). Peritoneal carcinosis in apparently benign cortisol producing adrenal adenoma >= 5 cm in diameter: the need of regular postoperative surveillance. (external link)
• Monica Mannelqvist; Elisabeth Wik; Ingunn Stefansson et al. (2014). An 18-Gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer. (external link)
• Maria Ramnefjell; Christina Aamelfot; Lars Helgeland et al. (2017). Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomas. (external link)
• Jone Trovik; Elisabeth Wik; Henrica Maria Johanna Werner et al. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. (external link)
• Helga Salvesen; Ingunn Marie Stefansson; EI Kretzschmar et al. (2004). Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression. (external link)
• Lars A. Akslen; Jan Erik Varhaug (1995). Oncoproteins and tumor progression in papillary thyroid carcinoma. Presence of epidermal growth factor receptor (EGF-R), c-erbB-2 protein, estrogen receptor related protein (29), p21-ras protein and proliferation indicators in relation to tumor recurrences and patient survival. (external link)
• Karin Collett; Ingunn Marie Stefansson; Johan Eide et al. (2005). A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. (external link)
• Leif M Hove; Lars A. Akslen (1999). Clinicopathological characteristics of melanomas of the hand. (external link)
• Hawa Nalwoga; Lavina Ahmed; Jarle Arnes et al. (2016). Strong expression of hypoxia-inducible factor-1α (HIF-1α) is associated with Axl expression and features of aggressive tumors in African breast cancer. (external link)
• JN Kitinya; MP Mbonde; HJ Guther et al. (1994). Ploidy and proliferative rates in carcinomas of the breast in Tanzania. (external link)
• Liv Cecilie Vestrheim Thomsen; Katrin Kleinmanns; Shamundeeswari Anandan et al. (2023). Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study. (external link)
• Emilia Signe Hugdahl; Ingeborg M. Bachmann; Cornelia Schuster et al. (2019). Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma. (external link)
• Ying Chen; Tor Audun Klingen; Hans Aas et al. (2021). Tumor-associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer. (external link)
• Hilde Eide Lien; Hege Fredriksen Berg; Mari Kyllesø Halle et al. (2023). Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. (external link)
• Kari Rostad; Monica Mannelqvist; Ole Johan Halvorsen et al. (2007). ERG upregulation and related ETS transcription factors in prostate cancer. (external link)
• Ingeborg M. Bachmann; Rita Grude Ladstein; Oddbjørn Straume et al. (2008). Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. (external link)
• PA Ellis; Per Eystein Lønning; Anne-Lise Børresen-Dale et al. (1997). Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. (external link)
• Lars A. Akslen; T. Haldorsen; Steinar Østerbø Thoresen et al. (1993). Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period. (external link)
• Oddbjørn Straume; Lars A. Akslen (2004). Lymphatic vessel density and prognosis in cutaneous melanoma. (external link)
• Lise Martine Ingebriktsen; Rasmus Olai Collett Humlevik; Amalie Abrahamsen Svanøe et al. (2024). Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features. (external link)
• Leiv M Hove; Lars Andreas Akslen (1987). Malignt melanom i hud. (external link)
• Lars A. Akslen; Hanne Eknes Puntervoll; Ingeborg M. Bachmann et al. (2008). Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. (external link)
• Ying Chen; Tor Audun Klingen; Hans Aas et al. (2023). CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis. (external link)
• Per Helsing; Dag André Nyrnoen; Sarah Ariansen et al. (2008). Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. (external link)
• Praveen Sharma; Narinder S Sahni; Robert Tibshirani et al. (2005). Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. (external link)
• Marit Valla; Patricia Mjønes; Monica J Engstrøm et al. (2018). Characterization of FGD5 expression in primary breast cancers and lymph node metastases. (external link)
• Lars A. Akslen; Andreas O Myking; Helga Salvesen et al. (1993). Prognostic impact of EGF-receptor in papillary thyroid carcinoma. (external link)
• M Paessler; FH Kreisel; VA Livolsi et al. (2002). Can we rely on pathologic parameters to define conservative treatment of papillary thyroid carcinoma?. (external link)
• Jane M. Heuch; Ivar Heuch; Lars A. Akslen et al. (1998). Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. (external link)
• Peder Gjengstø; Elisabeth Paus; OJ Halvorsen et al. (2005). Predictors of prostate cancer evaluated by receiver operating characteristics partial area index: a prospective institutional study. (external link)
• Tiina Jokela; Agnete Svendsen; Agata Rybicka et al. (2018). Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance. (external link)
• MP Mbonde; H Amir; Lars A. Akslen et al. (2001). Expression of oestrogen and progesterone receptorss, Ki-67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African poplation. (external link)
• Manuel Carrasco Fernandez; Ole Vidhammer Bjørnstad; Heidrun Vethe et al. (2025). Adrenergic signals influence proteomic responses in breast cancer cells. (external link)
• Soroush Oskouei; André Pedersen; Marit Valla et al. (2025). OKEN: A Supervised Evolutionary Optimizable Dimensionality Reduction Framework for Whole Slide Image Classification. (external link)
• Helga Salvesen; Lars A. Akslen; Torbjørn Iversen et al. (1997). Recurrent endometrial carcinoma and the value of routine follow-up. (external link)
• Martin Pilskog; Leif Bostad; Reidunn Jetne Edelmann et al. (2018). Tumour cell expression of interleukin 6 receptor a is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1997). Prognostisk betydning av tumorbiologiske markører ved kreft i livmorslimhinnen. (external link)
• Tor Audun Klingen; Ying Chen; Pål Suhrke et al. (2013). Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas. (external link)
• Emilia Signe Hugdahl; Sura Mohammed Aziz; Tor Audun Klingen et al. (2025). Prognostic value of immune biomarkers in melanoma loco-regional metastases. (external link)
• Lise Martine Ingebriktsen; Amalie Abrahamsen Svanøe; Anna Kristine Myrmel Sæle et al. (2024). Age-Related Clusters and Favorable Immune Phenotypes in Breast Cancer of the Young Patients. (external link)
• Helen Mackay; Elizabeth A. Eisenhauer; Suzanne Kamel-Reid et al. (2014). Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. (external link)
• E. Glattre; A. Høstmark; Steinar Østerbø Thoresen et al. (1990). Provocation of thyroid neoplasms in female Wistar rats fed n-3 or n-6 fatty acids in the feed. (external link)
• Ingfrid S. Haldorsen; Ingunn Stefansson; Renate Grüner et al. (2014). Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. (external link)
• Ingeborg Bachmann; Oddbjørn Straume; Hanne Eknes Puntervoll et al. (2005). Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. (external link)
• Sura Mohammed Aziz; Elisabeth Wik; Gøril Knutsvik et al. (2016). Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer. (external link)
• Maria Ramnefjell; Christina Aamelfot; Sura Mohammed Aziz et al. (2017). Microvascular proliferation is associated with aggressive tumour features and reduced survival in lung adenocarcinoma.. (external link)
• Helga Salvesen; Pål Rasmus Njølstad; Lars A. Akslen et al. (1991). Thyroid carcinoma: Results from surgical treatment in 211consecutive patients. (external link)
• Oddbjørn Straume; Takeshi Shimamura; Michael J.G. Lampa et al. (2012). Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. (external link)
• Dagny R. Faksvåg Haugen; JR Lillehaug; Lars A. Akslen (1999). Enhanced expression of EGF-receptor and low frequency of ras mutations in X-ray-induced rat thyroid tumours. (external link)
• G. O. Ness; Rolf Bjerkvig; Lars A. Akslen et al. (1996). Primary organ-culture of non neoplastic and neoplastic thyroid tissue as multicellular spheroids. (external link)
• Tor A Klingen; Heman Klaasen; Hans Aas et al. (2009). Secondary breast cancer: a 5-year population-based study with review of the literature. (external link)
• Amit Dutt; Helga Salvesen; Tzu-Hsiu Chent et al. (2008). Drug-sensitive FGFR2 mutations in endometrial carcinoma. (external link)
• Lars Andreas Akslen; Leiv M Hove; Flora Hartveit (1987). Metastatic distribution in malignant melanoma. A 30-year autopsy study.. (external link)
• Turid Aas; Stephanie Geisler; Trond H Paulsen et al. (1996). Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome. (external link)
• Silje Kjølle; Kenneth Finne; Even Birkeland et al. (2023). Hypoxia induced responses are reflected in the stromal proteome of breast cancer. (external link)
• Lavina Ahmed; Hawa Nalwoga; Jarle Arnes et al. (2015). Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African women. (external link)
• Ingeborg Margrethe Bachmann; Ole Johan Halvorsen; Karin Collett et al. (2006). EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. (external link)
• Marc Tischkowitz; Jean-Sébastien Brunet; Louis R. Bégin et al. (2007). Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. (external link)
• Ingeborg Bøe Engelsen; IM Stefansson; Lars A. Akslen et al. (2008). GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival. (external link)
• Ole Vidhammer Bjørnstad; Manuel Carrasco Fernandez; Kenneth Finne et al. (2024). Global and single-cell proteomics view of the co-evolution between neural progenitors and breast cancer cells in a co-culture model. (external link)
• Emilia Signe Hugdahl; May Britt Kalvenes; Hanne Eknes Puntervoll et al. (2016). BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival. (external link)
• Hawa Nalwoga; Jarle Arnes; Ingunn Marie Stefansson et al. (2011). Vascular proliferation is increased in basal-like breast cancer. (external link)
• Mikyung Kelly Seo; Oddbjørn Straume; Lars A. Akslen et al. (2020). HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?. (external link)
• Evita Maria Lindholm; Alexandr Kristian; Hawa Nalwoga et al. (2012). Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts. (external link)
• Rasmus Olai Collett Humlevik; Amalie Abrahamsen Svanøe; Turid Aas et al. (2025). Distinct clinicopathological features and treatment differences in breast cancer patients of young age. (external link)
• Karsten Gravdal; Ole Johan Halvorsen; Svein Andreas Haukaas et al. (2007). A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer. (external link)
• Emad A. Rakha; Somaia E. Elsheikh; Muhammed A. Aleskandarany et al. (2009). Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes. (external link)
• George N. Naumov; Lars A. Akslen; Judah Folkman (2006). Role of angiogenesis in human tumor dormancy - Animal models of the angiogenic switch. (external link)
• Ingeborg Bøe Engelsen; Monica Mannelqvist; Ingunn Marie Stefansson et al. (2008). Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. (external link)
• Karen Klepsland Mauland; Elisabeth Wik; Erling Andre Høivik et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (external link)
• Lars A. Akslen; Andreas O Myking; Odd Mørkve et al. (1990). Increased content of chronium and nickel in lung tissues patients with bronchial carcinoma. (external link)
• Helga Salvesen; Pål Rasmus Njølstad; Lars A. Akslen et al. (1992). Thyroid carcinoma. Results from surgical treatment in 211 consecutive patients. (external link)
• Geir Bredholt; Monica Mannelqvist; Ingunn Stefansson et al. (2015). Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. (external link)
• Wenliang Lia; Nanping Ai; Suming Wang et al. (2014). GRK3 is essential for metastatic cells and promotes prostate tumor progression. (external link)
• Solveig Hofvind; Gøril Knutsvik; Åsne Sørlien Holen et al. (2021). Detection and significance of small and low proliferation breast cancer. (external link)
• Tone Hovda; Marthe Larsen; Marie Burns Bergan et al. (2025). Retrospective evaluation of a CE-marked AI system, including 1,017,208 mammography screening examinations. (external link)
• Michael S. Rogers; Katherine Novak; David Zurakowski et al. (2014). Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors. (external link)
• Lars A. Akslen; E. Glattre (1992). Second malignancies in thyroid cancer patients: a population-based survey of 3658 cases from Norway. (external link)
• Ingfrid S. Haldorsen; Renate Grüner; Jenny Hild Aase Husby et al. (2013). Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. (external link)
• Tina Fonnes; Hege Fredriksen Berg; Therese Bredholt Onyango et al. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. (external link)
• Yngve Nygård; Svein Andreas Haukaas; Ole Johan Halvorsen et al. (2016). A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary biopsy. (external link)
• Anna Berg; Ankush Gulati; Sigmund Ytre-Hauge et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (external link)
• Dag Hoem; Oddbjørn Straume; Heike Immervoll et al. (2013). Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma. (external link)
• Rita Grude Ladstein; Ingeborg M. Bachmann; Oddbjørn Straume et al. (2014). Nestin expression is associated with aggressive cutaneous melanoma of the nodular type. (external link)
• Dagny R. Faksvåg Haugen; Lars A. Akslen; Jan Erik Varhaug et al. (1996). Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. (external link)
• Maria Lie Lotsberg; Katarzyna Wnuk-Lipinska; Stéphane Terry et al. (2020). AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells. (external link)
• Soroush Oskouei; Marit Valla; Andre Pedersen et al. (2025). Segmentation of Non-Small Cell Lung Carcinomas: Introducing DRU-Net and Multi-Lens Distortion. (external link)
• Svein Rotevatn; Lars A. Akslen; Elisabeth Bjerke (1989). Lifestyle and mortality among Norwegian men. (external link)
• Karsten Gravdal; Ole Johan Halvorsen; Svein Andreas Haukaas et al. (2006). Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer. (external link)
• Xisong Ke; Wencheng Li; Randi Hovland et al. (2011). Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. (external link)
• Else Marie Opsahl; Lars A. Akslen; Ellen Schlichting et al. (2018). Trends in diagnostics, surgical treatment, and prognostic factors for outcomes in medullary thyroid carcinoma in Norway: A nationwide population-based study. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Prognostic impact of morphometric nuclear grade of endometrial carcinoma. (external link)
• Yngve Nygård; Svein Andreas Haukaas; Geir Egil Eide et al. (2015). Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort. (external link)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (external link)
• Lars A. Akslen; SE Monstad; B Larsen et al. (1998). Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. (external link)
• Kaitlyn Tsuruda; Solveig Hofvind; Lars A. Akslen et al. (2019). Terminal digit preference: a source of measurement error in breast cancer diameter reporting. (external link)
• Lars A. Akslen; Andreas O Myking; Helga Salvesen et al. (1993). Prognostic impact of EGF-receptor in papillary thyroid carcinoma. (external link)
• Ingeborg M. Bachmann; Hanne Eknes Puntervoll; Arie P. Otte et al. (2008). Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. (external link)
• Rita Grude Ladstein; Ingeborg M. Bachmann; Oddbjørn Straume et al. (2012). Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma. (external link)
• Ingeborg Bøe Engelsen; Ingunn Marie Stefansson; Rameen Beroukhim et al. (2008). HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas. (external link)
• Hawa Nalwoga; Jarle Arnes; Henry Wabinga et al. (2008). Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women. (external link)
• Monica Mannelqvist; Ingunn Marie Stefansson; Elisabeth Wik et al. (2012). Lipocalin 2 expression is associated with aggressive features of endometrial cancer. (external link)
• Lars Anders Rokne Reisæter; Jurgen Fütterer; Ole Johan Halvorsen et al. (2015). 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy. (external link)
• Monica Hellesøy; Anna Blois; Crina Elena Tiron et al. (2014). Akt1 activity regulates vessel maturation in a tissue engineering model of angiogenesis. (external link)
• Jarle Arnes; LR Begin; JS Brunet et al. (2009). Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer. (external link)
• Anja Hegen; Anna Blois; Crina Elena Tiron et al. (2011). Efficient in vivo vascularization of tissue-engineering scaffolds. (external link)
• Lars A. Akslen; S. E. Monstad; B. Larsen et al. (1998). Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. (external link)
• GO Ness; Rolf Bjerkvig; Lars A. Akslen et al. (1995). Primary organ culture of non-neoplastic and neoplastic thyroid tissue multicellular spheroids. (external link)
• Kaitlyn Tsuruda; Sameer Bhargava; Lars A. Akslen et al. (2019). Forløpstider i Mammografi-programmet før og etter innføring av pakkeforløp for brystkreft. (external link)
• Helga B. Salvesen; Ingunn Marie Stefansson; May Britt Kalvenes et al. (2002). Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. (external link)
• Else Marie Opsahl; Michael Brauckhoff; Ellen Schlichting et al. (2016). A nationwide study of multiple endocrine neoplasia type 2A in Norway: predictive and prognostic factors for the clinical course of medullary thyroid carcinoma. (external link)
• Suming Wang; Anna Blois; Tina El Rayes et al. (2016). Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment. (external link)
• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2011). Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer. (external link)

Conference lecture

• Yngve Nygård; Ole Johan Halvorsen; Karsten Gravdal et al. (2010). Preliminære resultater av PCA3 måling i urin hos pasienter med cancer prostatae. (external link)
• Lars Anders Reisæter; Yngve Nygård; Ole Johan Halvorsen et al. (2010). Er preoperativ MR-prostata nyttig for å avklare korrekt T-stadium forut for kirurgi?. (external link)
• Yngve Nygård; Jo Erling Riise Waage; Ole Johan Halvorsen et al. (2010). Real time elastografi ved cancer prostatae. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1997). Independent prognostic importance of microvessel density in endometrial carcinoma. [poster]. (external link)
• Jan Erik Varhaug; Helge Boman; Lars A. Akslen (1998). Profylaktisk thyroidectomi hos barn - initial erfaring. (external link)
• Ole J. Halvorsen; A M Øyan; TH Bø et al. (2003). Gene expression profiling in prostate cancer: Cluster analysis and association with tumor differentiation. (external link)
• Xisong Ke; Anne Margrete Øyan; Kari Rostad et al. (2007). Functional oncogenomics and epigenomics analysis of prostate cancer. (external link)
• Martin Biermann; Boel Johnsen; Alexandru Gratian Naum et al. (2011). FDG-PET-CT, I-131-SPECT-CT, ultrasound (US) and US-guided fine needle biopsy (FNB) for recurrent differentiated thyroid cancer (DTC). (external link)
• OJ Halvorsen; Svein Andreas Haukaas; PÅ Høisæter et al. (1999). Prognostic importance of microvessel density (MVD) in clinically localized prostate cancer. (external link)
• Karl-Henning Kalland; Ole Johan Halvorsen; Anne Margrete Øyan et al. (2004). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue. (external link)
• Lars Anders Reisæter; Tor Wold; Svein Andreas Haukaas et al. (2010). Er MR-prostata nyttig for å avklare videre oppfølgningsbehov hos pasienter med 2 eller flere negative biopsiserier?. (external link)
• Monica J Engstrøm; Signe Opdahl; Anne Irene Hagen et al. (2013). Molekylære subtyper og overlevelse ved brystkreft. (external link)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2008). Polycomb group target genes and bivalent H3K4 & K27me3 modifications in human embryonic cells were enriched among dysregulated genes in prostate cancer. (external link)
• Sue Olsen; Trond Hellem Bø; Kari Rostad et al. (2003). Comparison of DNA microarray and real time quantitative PCR for quantitation of gene expression of selected genes in prostate cancer. (external link)
• Kari Rostad; Monica Mannelqvist; Ole Johan Halvorsen et al. (2006). ERG upregulation and related transcription factors in prostate cancer. (external link)
• Karl-Henning Kalland; Kari Rostad; Monica Mannelqvist et al. (2006). Global gene expression analysis of transcription factors in prostate cancer and cell lines. (external link)
• Xisong Ke; Wencheng Li; Yi Qu et al. (2009). EMT Promotes Malignant Transformation of Prostate Epithelial Cells in Culture. (external link)
• Martin Biermann; Boel Johnsen; Alexandru Gratian Naum et al. (2011). Multimodal imaging for diagnosis and treatment of recurrent differentiated thyroid cancer (DTC)FDG-PET-CT, contrast-enhanced CT (CE-CT), I-131-SPECT-CT, ultrasound (US) and US-guided fine needle biopsy (FNB). (external link)
• Monica J Engstrøm; Signe Opdahl; Åse Kristin Skain Hansen et al. (2013). Molekylære subtyper og overlevelse ved brystkreft. (external link)
• Ole J. Halvorsen; Sven Haukaas; Per Åge Høisæter et al. (2001). Prognostisk betydning av angiogenese (microvessel density - MVD) og proliferasjonsmarkøren Ki-67 ved lokalisert prostatacencer. (external link)
• Martin Biermann; Boel Johnsen; Alexandru Gratian Naum et al. (2010). Multimodal imaging of differentiated thyroid cancer: FDG-PET-CT, I-131-SPECT-CT and ultrasound. (external link)
• Karl-Henning Kalland; Lars A. Akslen; Ole J. Halvorsen et al. (2003). DNA microarray studies of human cancer - pitfalls and outlook. (external link)
• OJ Halvorsen; Svein Andreas Haukaas; PÅ Høisæter et al. (1998). Prognostic importance of microvessel density (MVD) in clinically localized prostate cancer. (external link)
• Liv Cecilie Vestrheim Thomsen; Alfred Honore; Lars Anders Rokne Reisæter et al. (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC). (external link)
• Kari Rostad; Thorsten Schlomm; Svein Andreas Haukaas et al. (2007). Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients and identification of ERG target genes. (external link)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (external link)
• Siver Andreas Moestue; Else Marie Huuse; Evita Maria Lindholm et al. (2011). Early vascular response to bevacizumab treatment measured by DCE-MRI in breast cancer xenografts. (external link)
• Karl-Henning Kalland; Ole J. Halvorsen; Anne Margrete Øyan et al. (2003). Global analysis of gene expression and regulatory patterns in urogenital tumours using DNA microarrays. (external link)
• Anders Molven; H Immervold; K Kugarajh et al. (2003). Mutation analysis of the RAS-RAF pathway in pancreatic adenocarcinomas and malignant melanomas. (external link)
• Martin Biermann; Boel Johnsen; Alexandru Gratian Naum et al. (2012). Multimodal imaging for suspected recurrent differentiated thyroid cancer (DTC): FDG-PET-CT, I-131-SPECT-CT, ultrasound (US) and US-guided fine needle biopsy (FNB). (external link)
• Else Marie Huuse; Siver Andreas Moestue; Evita Lindholm et al. (2010). In vivo magnetic resonance imaging and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. (external link)
• Ole Johan Halvorsen; Anne Margrete Øyan; Trond Hellem Bø et al. (2003). Gene expression profiling in prostate cancer: cluster analysis and association with tumor differentation. (external link)
• Ole J. Halvorsen; Anne Margrete Øyan; Trond Hellem Bø et al. (2003). Gene expression profiling in prostate cancer. (external link)
• Siver Andreas Moestue; Else Marie Huuse; Evita Maria Lindholm et al. (2011). DCE-MRI for early therapy monitoring of anti-angiogenic therapy. (external link)
• Karl-Henning Kalland; Anne Margrete Øyan; Lars A. Akslen et al. (2003). Global analysis of gene expression and regulatory patterns in cancer. (external link)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2008). Epithelial to mesenchymal transition of a primary, immortalized prostate cell line is associated with gene expression switches of entire cell attachment modules. (external link)
• Marit Valla; Monica J Engstrøm; Borgny Ytterhus et al. (2016). FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis. (external link)
• EM Opsahl; Turid Aas; Trond Harder Paulsen et al. (2002). Cancer mammae behandlet med brystbevarende kirurgi ved Haukeland sykehus 1984-1995. (external link)
• Marit Valla; Lars Johan Vatten; Monica J Engstrøm et al. (2016). Molecular subtypes of breast cancer: long-term incidence trends and prognostic differences. (external link)
• LM Hove; Lars A. Akslen (1998). Malignant melanoma of the hand. A 25-year clinico-pathological study. (external link)
• LM Hove; Lars A. Akslen (1998). Malignt melanom på hender. (external link)
• S. Rotevatn; Lars A. Akslen; Erik Bjelke (1989). Mortality form ischemic heart disease related to life-style differences among Norwegian men (Abstract). (external link)
• Else Marie Huuse; Siver Andreas Moestue; Tone Frost Bathen et al. (2011). In vivo Dynamic Contrast Enhanced MRI & Histopathological Assessment of Tumor Angiogenesis in Luminal-like and Basal-like Breast Cancer Xenografts. (external link)

Academic book chapter

• Heidrun Vethe; Ole Vidhammer Bjørnstad; Manuel Carrasco Fernandez et al. (2022). Neurogenesis in the Tumor Microenvironment. (external link)
• Lars A. Akslen (2008). Pathology of Breast Tumors in Hereditary Breast Cancer. (external link)
• Anne Bremer; Elisabeth Wik; Lars Andreas Akslen (2022). HER2 Revisited: Reflections on the Future of Cancer Biomarker Research. (external link)
• Maria Paula Ramnefjell; Lars Andreas Akslen (2022). Tumor-Vascular Interactions in Non-Small Cell Lung Cancer. (external link)
• Vladan Milosevic; Reidunn Jetne Edelmann; Johanna Hol Fosse et al. (2022). Molecular Phenotypes of Endothelial Cells in Malignant Tumors. (external link)
• Lars A. Akslen (2017). Tissue-Based Biomarkers of Tumor-Vascular Interactions. (external link)
• Elisabeth Wik; Lars A. Akslen (2017). Gene expression signatures of the tumor microenvironment: relation to tumor progress in breast cancer. (external link)

Conference poster

• Liv Cecilie Vestrheim Thomsen; Alfred Honore; Lars Anders Rokne Reisæter et al. (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC). (external link)
• Monica Mannelqvist; Trond Hellem Bø; Geir Bredholt et al. (2007). Patterns of gene expression related to vascular invasion and aggressive features in endometrial cancer. (external link)
• Monica Mannelqvist; Trond Hellem Bø; Geir Bredholt et al. (2007). Patterns of gene expression related to vascular invasion and aggressive features in endometrial cancer. (external link)
• Helga Salvesen; Lars A. Akslen; Grethe Albrektsen et al. (1997). Decreased survival for nulliparous women with endometrial carcinoma. Is the relationship dur to biology or behaviour? [poster]. (external link)
• Maria Ramnefjell; Christina Aamelfot; Lars Helgeland et al. (2016). Low Expression of SerpinB2 is Associated With Reduced Survival in Lung Adenocarcinomas. (external link)
• Maria Ramnefjell; Christina Aamelfot; Lars Helgeland et al. (2016). Microvascular proliferation is Associated With Aggressive Tumor Features and Reduced Survival in Lung Adenocarcinomas. (external link)
• Karl-Henning Kalland; Ole Johan Halvorsen; Kari Rostad et al. (2005). Very high expression of specific transcription factors in prostate cancer compared with paired benign prostate tissue. (external link)
• Sven Haukaas; Ole J. Halvorsen; Lars Dæhlin et al. (2003). Preoperative PSA may not be a predictor of clinical recurrence after radical prostatectomy. (external link)
• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2009). Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer. (external link)
• Xisong Ke; Yi Qu; Naomi Goldfinger et al. (2009). A novel model of stepwise prostate carcinogenesis in culture. (external link)
• Xisong Ke; Wencheng Li; Yi Qu et al. (2009). Stepwise prostate carcinogenesis in vitro culture. (external link)
• Lars A. Akslen; Rolf Bjerkvig; Knut-Jan Andersen et al. (1986). Glioma Cells Cultured Under Serum Free Conditions. (external link)
• Ole Johan Halvorsen; Kari Rostad; Anne Margrete Øyan et al. (2006). Single-minded 2 homolog (SIM2) is overexpressed in prostate cancer. (external link)
• Maria Ryssdal Kraby; Signe Opdahl; Kristi Krüger et al. (2014). Microvascular proliferation in breast cancer. (external link)
• Monica J Engstrøm; Signe Opdahl; Pål Richard Romundstad et al. (2014). Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients. (external link)
• Rosmari Monsen; Randi Jøsok; Lars A. Akslen et al. (1986). Secretion of Lysosomal Glycosidases from Human and Rat Brain Tumour Cell Lines. (external link)
• Karl-Henning Kalland; Ole Johan Halvorsen; Monica Mannelqvist et al. (2005). ETS transcription factors in prostate cancer. (external link)
• Ole Johan Halvorsen; Kari Rostad; Anne Margrete Øyan et al. (2005). Single-minded 2 homolog gene (SIM2) is overexpressed in prostate cancer. (external link)
• Sven Haukaas; Ole J. Halvorsen; Lars Dæhlin et al. (2003). Preoperative PSA may not be a predictor of clinical recurrence after radical prostatectomy. (external link)
• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2009). Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer. (external link)
• Xisong Ke; Yi Qu; Naomi Goldfinger et al. (2009). A novel model of stepwise prostate carcinogenesis in culture. (external link)
• Xisong Ke; Wencheng Li; Yi Qu et al. (2009). Stepwise prostate carcinogenesis in vitro culture. (external link)
• Martin Biermann; Boel Johnsen; Alexandru Gratian Naum et al. (2010). Multimodal imaging for recurrent differentiated thyroid cancer: Ultrasound, I-131-SPECT-CT, FDG-PET-CT and fine-needle biopsy. (external link)
• Martin Biermann; Bernt Christian Reitan; Boel Johnsen et al. (2012). False positive FDG-uptake in neck and mediastinum in recurrent differentiated thyroid cancer (DTC). (external link)
• Ole J. Halvorsen; Sven Haukaas; Lars A. Akslen (2002). Expression of PTEN/P27 proteins in prostate cancer using a tissue microarray setup predicts progression after radical prostatectomy. (external link)
• Marit Valla; Lars Johan Vatten; Monica J Engstrøm et al. (2016). Molecular subtypes of breast cancer: Long term incidence trends and prognostic differences. (external link)
• Sven Haukaas; Ole J. Halvorsen; Lars Dæhlin et al. (2003). Preoperative PSA may not be a predictor of clinical recurrence after radical prostatectomy. (external link)
• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2009). Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer. (external link)
• Xisong Ke; Yi Qu; Naomi Goldfinger et al. (2009). A novel model of stepwise prostate carcinogenesis in culture. (external link)
• Xisong Ke; Wencheng Li; Yi Qu et al. (2009). Stepwise prostate carcinogenesis in vitro culture. (external link)
• Xisong Ke; Yi Qu; Ole Johan Halvorsen et al. (2008). Polycomb (PcG) targets are enriched in repressed genes in prostate cancer. (external link)
• Kari Rostad; Monica Mannelqvist; Ole Johan Halvorsen et al. (2006). ERG upregulation in relation to other transcription factors in prostate cancer. (external link)
• Karl-Henning Kalland; Ole J. Halvorsen; Anne Margrete Øyan et al. (2003). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue. (external link)
• Siver Andreas Moestue; Silje Flatabø; Else Marie Huuse et al. (2012). Metabolic responses to VEGF inhibition in patient-derived breast cancer xenografts. (external link)
• Oddbjørn Straume; Takeshi Shimamura; Anne Margrete Øyan et al. (2009). Suppression of heat shock Protein 27 induces long-term dormancy in human breast cancer. (external link)
• Xisong Ke; Yi Qu; Kari Rostad et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (external link)
• Kari Rostad; Thorsten Schlomm; Svein Andreas Haukaas et al. (2007). Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients. (external link)
• Helga Salvesen; Trond Hellem Bø; Ingunn Marie Stefansson et al. (2006). Gene expression profiles identify an aggressive phenotype in endometrial carcinoma. (external link)
• Maria Ryssdal Kraby; Kristi Krüger; Signe Opdahl et al. (2016). Microvascular proliferation in breast cancer. (external link)
• Xisong Ke; Yi Qu; Naomi Goldfinger et al. (2009). Epithelial to mesenchymal transition of a primary prostate cell line before malignant transformation with switches of cell adhesion modules. (external link)
• Ingrid Moen; Anne Margrete Øyan; Karl-Henning Kalland et al. (2009). Hyperoxic Treatment induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model. (external link)

Lecture

• Helga Salvesen; Lars A. Akslen; Ole-Erik Iversen (1997). Recurrent endometrial and the value of routine follow up. (external link)
• Maria Ryssdal Kraby; Kristi Krüger; Signe Opdahl et al. (2016). Microvascular proliferation in breast cancer. (external link)
• Maria Ryssdal Kraby; Kristi Krüger; Signe Opdahl et al. (2015). Microvascular proliferation in the Luminal A and Basal-like subtypes of breast cancer (AM Bofin). (external link)
• Helga Salvesen; Lars A. Akslen; Ole-Erik Iversen (1997). Angiogenese - en ny og sterk prognostisk faktor ved endometriecarcinom. (external link)
• Helga Salvesen; Lars A. Akslen; Ole-Erik Iversen (1997). Angiogenese - en ny og sterk prognostisk faktor ved endometriecarcinom. (external link)
• Karl-Henning Kalland; Ole Johan Halvorsen; Kari Rostad et al. (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer. (external link)

Book anthology

• Lars Andreas Akslen; Randolph S. Watnick (2022). Biomarkers of the Tumor Microenvironment. (external link)
• Lars A. Akslen; Randolph S. Watnick (2017). Biomarkers of the Tumor Microenvironment: Basic Studies and Practical Applications. (external link)

Letter to the editor

• WD Foulkes; Lars A. Akslen (2004). Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer. (external link)
• George N. Naumov; John Heymach; Lars A. Akslen (2008). Dr. Folkman's legacy - a life of angiogenesis research. (external link)
• Lars A. Akslen; GK Jacobsen; O Vainio (2004). Angiogenesis - recent developments in molecular pathogenesis, morphological markers, and therapeutic applications. (external link)
• George N. Naumov; Randolph S. Watnick; Nava Almog et al. (2007). Re: A model of human tumor dormancy: An angiogenic escape from the nonangiogenic phenotype - Response. (external link)
• Jone Trovik; Elisabeth Wik; Ingunn Marie Stefansson et al. (2010). Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer. (external link)
• Hanne Eknes Puntervoll; Anders Molven; Lars A. Akslen (2014). Frequency of somatic BRAF mutations in melanocytic lesions from patients in a CDK4 melanoma family. (external link)
• Hanne Eknes Puntervoll; Anders Molven; Lars A. Akslen (2014). Frequencies of KIT and GNAQ mutations in acral melanoma. (external link)

Conference abstract

• H Nalwoga; Jarle Arnes; H Wabinga et al. (2007). Basal-like phenotype is frequent in invasive breast carcinoma from Ugandan Africans and is strongly associated with a high expression of EGFR/c-Kit and features of aggressive tumors. (external link)
• Karsten Gravdal; Ole Johan Halvorsen; Svein Andreas Haukaas et al. (2007). Epithelial to mesenchymal transition is of strong prognostic importance in prostate cancer. (external link)
• Karl-Henning Kalland; Ole Johan Halvorsen; Kari Rostad et al. (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer. (external link)
• Kari Rostad; Monica Mannelqvist; Ole Johan Halvorsen et al. (2006). ERG upregulation in relation to other transcription factors in prostate cancer. (external link)
• Gøril Knutsvik; Ingunn Marie Stefansson; Karin Collett et al. (2012). Prognostic impact of proliferation markers Ki-67, PHH3 and mitotic count in breast carcinomas. (external link)
• Ingvild Løberg Tangen; Camilla Krakstad; Henrica Maria Johanna Werner et al. (2013). FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. (external link)
• Gøril Knutsvik; Ingunn Marie Stefansson; Karin Collett et al. (2013). Proliferation markers PHH3, Ki67 and Mimtotic count all show significant associations with features of aggressive breast carcinomas and reduced survival. (external link)
• Ingeborg M. Bachmann; HE Eknes; Ariel P. Otte et al. (2007). Loss of BMI-1 expression is associated with the clinical progress of malignant melanoma. (external link)
• Hawa Nalwoga; Jarle Arnes; H Wabinga et al. (2012). Expression of hypoxia-inducible factor-1a and associations with vascular endothelial growth factor expression, high microvessel density and features of aggressive tumors in African breast cancer. (external link)
• Karsten Gravdal; Ole Johan Halvorsen; Svein Andreas Haukaas et al. (2009). Proliferation of immature tumor vessels is a novel marker of clinical progress in prostate cancer. (external link)
• Ole Johan Halvorsen; Kari Rostad; Anne Margrete Øyan et al. (2005). Single-minded 2 homolog gene is overexpressed in prostate cancer. (external link)
• Karsten Gravdal; Ole Johan Halvorsen; Svein Andreas Haukaas et al. (2008). Vascular proliferation by Nestin/Ki-67 is a novel predictor of the clinical progress of prostate cancer. (external link)
• Elisabeth Wik; Maria Rader; Camilla Krakstad et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (external link)
• Crina Elena Tiron; Christine Gjerdrum; Torill Høiby et al. (2011). Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. (external link)
• Gøril Knutsvik; Ingunn Marie Stefansson; Karin Collett et al. (2013). Proliferation markers PHH3, Ki67 and mitotic count all show significant associations with features of aggressive breast carcinomas and reduced survival. (external link)
• Siver Andreas Moestue; Silje Flatabø; Else Marie Huuse et al. (2012). Metabolic Responses to VEGF Inhibition in Patient-derived Breast Cancer Xenografts. (external link)
• Martin Biermann; Boel Johnsen; Alexandru Gratian Naum et al. (2010). Multimodal imaging of differentiated thyroid cancer: FDG-PET-CT, I-131-SPECT-CT and ultrasound [Abstract]. (external link)
• Ingunn Marie Stefansson; M Mannelquist; HB Salvesen et al. (2010). Prognostic importance of vascular proliferation and tumor cell invasion in blood and lymphatic vessels in endometrial carcinoma. (external link)
• Jarle Arnes; William D. Foulkes; Lars A. Akslen (2008). Candidate stem cell marker ALDH1 expression and relationship with BRCA-mutations and basal-like differentiation in breast carcinoma. (external link)

Research report

• Dagny R. Faksvåg Haugen; Lars A. Akslen; Johan Lillehaug et al. (1993). Expression of c-erbB-2, TGF-_a, EGF receptor and c-myc in thyroid tumors. An immunohistochemical study using frozen tissue. (external link)
• Lars Andreas Akslen; Karl Henning Kalland (2023). Annual Report 2022 Centre for Cancer Biomarkers. (external link)

Doctoral thesis (PhD)

• Tor Audun Klingen; Lars A. Akslen (2018). Vascular invasion by tumor cells, and other prognostic factors in a population-based breast cancer study. (external link)
• Kristi Krüger; Lars A. Akslen (2017). Markers of angiogenesis and the basal-like phenotype of breast cancer. (external link)
• Lavina Ahmed; Lars A. Akslen (2016). Axl as a Biomarker in Breast and Lung Cancer. (external link)
• Lars A. Akslen (1993). Thyroid cancer. A study of incidence pattern, pathological features and prognosis. (external link)
• Maria Ramnefjell; Lars A. Akslen; Lars Helgeland (2018). Prognostic biomarkers and clinico-pathologic characteristics in non-small cell lung cancer. A study with special focus on tumor-vascular interactions. (external link)
• Emilia Hugdahl; Lars A. Akslen (2018). Prognostic and molecular markers in primary and metastatic cutaneous melanoma. (external link)
• Sura Mohammed Aziz; Lars A. Akslen (2017). Biological and clinico-pathologic markers in breast cancer. With focus on histologic features, markers of proliferation and angiogenesis. (external link)
• Gøril Knutsvik; Lars A. Akslen (2016). Biomarkers in breast cancer, with special focus on tumor cell proliferation. (external link)

Academic literature review

• George N. Naumov; Judah Folkman; Oddbjørn Straume et al. (2008). Tumor-vascular interactions and tumor dormancy. (external link)
• Ingeborg Bøe Engelsen; Lars A. Akslen; Helga Birgitte Salvesen (2009). Biologic markers in endometrial cancer treatment. (external link)
• Jürgen Geisler; Ingeborg M. Bachmann; Marta Sølvi Nyakas et al. (2013). Malignt melanom – diagnostikk, behandling og oppfølging i Norge. (external link)

Media feature article

• Lars A. Akslen (1993). P53 immunostaining in melanocytic lesions. (external link)
• Trond H Paulsen; Turid Aas; A-L Børresen et al. (1997). Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. (external link)
• Lars A. Akslen; Bjørn Ove Mæhle (1997). Papillary thyroid carcinoma with lipomatous stroma. (external link)
• Lars A. Akslen (1994). Sol deg med forsiktighet !. (external link)
• O Straume; Lars A. Akslen (1997). Prognostic importance of melanoma diameter. (external link)
• Roger Strand; Lars A. Akslen (2017). Hva er ansvarlig kreftforskning?. (external link)
• Lars A. Akslen (1995). Melanoma and sun exposure (letter). (external link)
• Lars A. Akslen (1995). Seasonal variation in melanoma progress. (external link)

Popular science article

• Ole-Erik Iversen; Helga Salvesen; Lars A. Akslen (1998). Prognostisk betydning av tumorbiologiske markører. (external link)
• Helga Salvesen; Ole-Erik Iversen; Lars A. Akslen (1998). Prognostisk betydning av tumorbiologiske markører ved livmorkreft. (external link)

Master’s thesis

• Hanne Bjelland Litlabø; Kenneth Finne; Lars A. Akslen (2018). Effects of Breast Cancer Cell Secretomes on Mammary Fibroblast Phenotype. (external link)

Non-fiction book chapter

• Elisabeth Wik; Lise Martine Ingebriktsen; Lars Andreas Akslen (2022). Gene Expression Signatures of the Tumor Micoenvironment: Relation to Tumor Phenotypes and Progress in Breast Cancer. (external link)
• Lars Andreas Akslen (2022). Tissue-Based Biomarkers of Tumor-Vascular Interactions. (external link)

Introduction

• Lars A. Akslen; Randolph S. Watnick (2017). Preface. (external link)

Journal corrigendum

• David L. Duffy; Gu Zhu; Xin Li et al. (2019). Erratum to: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (Nature Communications, (2018), 9, 1, (4774), 10.1038/s41467-018-06649-5). (external link)
• Hilde Eide Lien; Hege Fredriksen Berg; Mari Kyllesø Halle et al. (2023). Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595] (eBioMedicine (2023) 92, (S2352396423001603), (10.1016/j.ebiom.2023.104595)). (external link)

Encyclopedia

• Lars Andreas Akslen; G. Cecilie Alfsen; Ying Chen (2023). Faget og foreningen gjennom 100 år. Den Norske Patologforening 1923-2023.. (external link)

Editorial/Leader article

• Lars A. Akslen; George N. Naumov (2008). Tumor dormancy - from basic mechanisms to clinical practice. (external link)

See a complete overview of publications in NVA.